藥明康德與沙特新未來城和沙特衛(wèi)生部簽署戰(zhàn)略合作備忘錄，計(jì)劃在當(dāng)?shù)赝卣笴RDMO平臺(tái)服務(wù) | Bilingual News

上海，2025年10月28日 – 藥明康德今日宣布已與沙特新未來城（NEOM）和沙特衛(wèi)生部分別簽署戰(zhàn)略合作備忘錄。NEOM是沙特西北部建設(shè)中的可持續(xù)發(fā)展新城。

藥明康德將與NEOM攜手合作，探索在沙特開展新藥研發(fā)與生產(chǎn)服務(wù)的本地化進(jìn)程。此次合作為公司未來在NEOM的先進(jìn)、清潔制造城市Oxagon或沙特其他地區(qū)建立世界一流的CRDMO研發(fā)及生產(chǎn)基地奠定了基礎(chǔ)。藥明康德將憑借其獨(dú)特的專業(yè)能力與全球網(wǎng)絡(luò)，持續(xù)推動(dòng)醫(yī)藥創(chuàng)新，助力當(dāng)?shù)厣锛夹g(shù)產(chǎn)業(yè)的加速發(fā)展。

▲藥明康德與沙特新未來城簽署戰(zhàn)略合作備忘錄

作為行業(yè)值得信賴的合作伙伴，此次合作匯聚了藥明康德服務(wù)全球生物醫(yī)藥行業(yè)二十多年的深厚經(jīng)驗(yàn)，以及NEOM致力于推動(dòng)創(chuàng)新、構(gòu)建未來生態(tài)圈的承諾。合作備忘錄的簽署，為藥明康德提供了重要的發(fā)展契機(jī)。公司將借助NEOM在可持續(xù)發(fā)展、創(chuàng)新與人才領(lǐng)域的戰(zhàn)略優(yōu)勢(shì)，將一體化賦能平臺(tái)更好地融入當(dāng)?shù)厣锛夹g(shù)發(fā)展的宏偉藍(lán)圖。

同時(shí)，藥明康德與沙特衛(wèi)生部的合作將重點(diǎn)聚焦醫(yī)藥產(chǎn)業(yè)價(jià)值鏈的本地化、大規(guī)模培養(yǎng)醫(yī)藥行業(yè)人才，以及吸引外商直接投資。

通過此次與沙特新未來城和衛(wèi)生部的合作，藥明康德將進(jìn)一步賦能全球客戶，不斷加速從新藥發(fā)現(xiàn)、開發(fā)到生產(chǎn)的全流程，造福全球病患。

關(guān)于藥明康德

藥明康德（股票代碼：603259.SH/2359.HK）是全球醫(yī)藥及生命科學(xué)行業(yè)值得信賴的合作伙伴和重要貢獻(xiàn)者，致力于通過提供一體化、端到端的新藥研發(fā)和生產(chǎn)服務(wù)，推動(dòng)全球醫(yī)藥健康創(chuàng)新。公司在亞洲、歐洲、北美等地均設(shè)有運(yùn)營(yíng)基地，依托獨(dú)特的“CRDMO”業(yè)務(wù)模式，不斷降低研發(fā)門檻，助力客戶提升研發(fā)效率，為患者帶來突破性的治療方案。目前，公司的賦能平臺(tái)正承載著來自全球30多個(gè)國家的約6,000家合作伙伴的研發(fā)創(chuàng)新項(xiàng)目，致力于將更多新藥、好藥帶給全球病患，早日實(shí)現(xiàn)“讓天下沒有難做的藥，難治的病”的愿景。

關(guān)于沙特新未來城（NEOM）

NEOM是推動(dòng)人類進(jìn)步的加速器，也是對(duì)“新未來”藍(lán)圖的展望。其位于沙特阿拉伯西北部，毗鄰紅海，正在從零起步打造一個(gè)“生活實(shí)驗(yàn)場(chǎng)”——在這里，創(chuàng)業(yè)精神將引領(lǐng)新未來城的發(fā)展方向。NEOM將成為那些胸懷遠(yuǎn)大理想、希望參與構(gòu)建卓越宜居新模式的人們的目的地與家園，致力于促進(jìn)企業(yè)蓬勃發(fā)展并重塑環(huán)境保護(hù)。

NEOM包括超互聯(lián)的認(rèn)知城市、港口與產(chǎn)業(yè)園區(qū)、研究中心、體育與娛樂設(shè)施，以及旅游目的地。作為創(chuàng)新樞紐，創(chuàng)業(yè)者、企業(yè)領(lǐng)袖與公司將來此開展研究，孵化項(xiàng)目，并開創(chuàng)性地將新技術(shù)與新業(yè)態(tài)商業(yè)化。NEOM的居民將展現(xiàn)國際化精神，擁有探索未知、敢于冒險(xiǎn)、多元包容的文化特質(zhì)。

欲了解更多信息，請(qǐng)發(fā)送郵件至 media@neom.com，或訪問www.neom.com與 www.neom.com/en-us/newsroom。

WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health

Shanghai, October 28, 2025 – WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced it has signed two strategic memoranda of understanding (MoUs) with NEOM, the sustainable region under development in northwest Saudi Arabia and the Ministry of Health of the Kingdom of Saudi Arabia (MOH).

WuXi AppTec and NEOM have agreed to collaborate to explore the localization of pharmaceutical research, development and manufacturing in Saudi Arabia. The agreement lays the groundwork for establishing world-class CRDMO facilities at Oxagon, NEOM’s advanced and clean manufacturing city, or other locations in Saudi Arabia. By leveraging WuXi AppTec’s unique expertise and global network, the initiative aims to drive innovation and accelerate the growth of the biotechnology sector in Saudi Arabia.

▲WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia

as It Signs Strategic MoU with NEOM

This partnership brings together WuXi AppTec’s decades of experience as a trusted partner to the global biopharmaceutical industry with NEOM’s commitment to fostering innovation and building a future-focused ecosystem. The MoU offers a compelling opportunity to extend WuXi AppTec’s integrated capabilities into a market with ambitious national biotechnology goals. It also capitalizes on NEOM’s visionary approach to sustainability, innovation, and talent development.

The MoU with MOH will focus on localizing the pharmaceutical value chain, developing a pharmaceutical workforce at scale and attracting foreign direct investment.

Together, the two MoUs will further advance WuXi AppTec’s mission to help customers and partners discover, develop and manufacture pharmaceuticals and healthcare products to benefit patients globally, including the broader MENA region.

About WuXi AppTec

WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients – one collaboration at a time. Learn more at www.wuxiapptec.com.

About NEOM

NEOM is an accelerator of human progress and a vision of what a New Future might look like. It is a region in northwest Saudi Arabia on the Red Sea being built from the ground up as a living laboratory – a place where entrepreneurship will chart the course for this New Future. It will be a destination and a home for people who dream big and want to be part of building a new model for exceptional liveability, creating thriving businesses and reinventing environmental conservation.

NEOM will include hyperconnected, cognitive cities, ports and enterprise zones, research centers, sports and entertainment venues and tourist destinations. As a hub for innovation, entrepreneurs, business leaders and companies will come to research, incubate and commercialize new technologies and enterprises in groundbreaking ways. Residents of NEOM will embody an international ethos and embrace a culture of exploration, risk-taking and diversity.

For further information email media@neom.com or visit www.neom.com and www.neom.com/en-us/newsroom.

免責(zé)聲明：本文 僅作信息交流之目的，文中觀點(diǎn)不代表藥明康德立場(chǎng)，亦不代表藥明康德支持或反對(duì)文中觀點(diǎn)。本文也不是治療方案推薦。如需獲得治療 方案指導(dǎo)，請(qǐng)前往正規(guī)醫(yī)院就診。

版權(quán)說明：歡迎個(gè)人轉(zhuǎn)發(fā)至朋友圈，謝絕媒體或機(jī)構(gòu)未經(jīng)授權(quán)以任何形式轉(zhuǎn)載至其他平臺(tái)。轉(zhuǎn)載授權(quán)請(qǐng)?jiān)凇杆幟骺档隆刮⑿殴娞?hào)回復(fù)“轉(zhuǎn)載”，獲取轉(zhuǎn)載須知。